| Epidemiologic classification of human papillomavirus types associated with cervical cancer N Muñoz, FX Bosch, S De Sanjosé, R Herrero, X Castellsagué, KV Shah, ... New England journal of medicine 348 (6), 518-527, 2003 | 9384 | 2003 |
| Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis M Arbyn, E Weiderpass, L Bruni, S de Sanjosé, M Saraiya, J Ferlay, ... The Lancet Global Health 8 (2), e191-e203, 2020 | 3399 | 2020 |
| Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study S de Sanjose, WGV Quint, L Alemany, DT Geraets, JE Klaustermeier, ... The lancet oncology 11 (11), 1048-1056, 2010 | 2984 | 2010 |
| Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis S De Sanjosé, M Diaz, X Castellsagué, G Clifford, L Bruni, N Muñoz, ... The Lancet infectious diseases 7 (7), 453-459, 2007 | 2308 | 2007 |
| Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings L Bruni, M Diaz, M Castellsagué, E Ferrer, FX Bosch, S de Sanjosé Journal of Infectious Diseases 202 (12), 1789-1799, 2010 | 2042 | 2010 |
| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ... Nature 475 (7354), 101-105, 2011 | 1906 | 2011 |
| Against which human papillomavirus types shall we vaccinate and screen? The international perspective N Muñoz, FX Bosch, X Castellsagué, M Díaz, S De Sanjose, ... International journal of cancer 111 (2), 278-285, 2004 | 1750 | 2004 |
| Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women … PA van den Brandt, RA Goldbohm, V Berol British journal of cancer 87 (11), 1234-1245, 2002 | 1658 | 2002 |
| Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis GM Clifford, S Gallus, R Herrero, N Munoz, PJF Snijders, S Vaccarella, ... The Lancet 366 (9490), 991-998, 2005 | 1588 | 2005 |
| Worldwide burden of cervical cancer in 2008 M Arbyn, X Castellsagué, S de Sanjosé, L Bruni, M Saraiya, F Bray, ... Annals of oncology 22 (12), 2675-2686, 2011 | 1580 | 2011 |
| Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of causality FX Bosch, S De Sanjosé JNCI monographs 2003 (31), 3-13, 2003 | 1437 | 2003 |
| Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia FX Bosch, AN Burchell, M Schiffman, AR Giuliano, S de Sanjose, L Bruni, ... Vaccine 26, K1-K16, 2008 | 1283 | 2008 |
| Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners X Castellsagué, FX Bosch, N Muñoz, CJLM Meijer, KV Shah, ... New England journal of medicine 346 (15), 1105-1112, 2002 | 1241 | 2002 |
| Human papillomavirus types in 115,789 HPV‐positive women: a meta‐analysis from cervical infection to cancer P Guan, R Howell‐Jones, N Li, L Bruni, S De Sanjosé, S Franceschi, ... International journal of cancer 131 (10), 2349-2359, 2012 | 1116 | 2012 |
| Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention X Castellsagué, M Díaz, S De Sanjosé, N Muñoz, R Herrero, S Franceschi, ... Journal of the National Cancer Institute 98 (5), 303-315, 2006 | 1040 | 2006 |
| Epidemiology and transmission dynamics of genital HPV infection AN Burchell, RL Winer, S de Sanjosé, EL Franco Vaccine 24, S52-S61, 2006 | 969 | 2006 |
| Carcinogenic human papillomavirus infection M Schiffman, J Doorbar, N Wentzensen, S De Sanjosé, C Fakhry, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 968 | 2016 |
| HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis C Ndiaye, M Mena, L Alemany, M Arbyn, X Castellsagué, L Laporte, ... The Lancet Oncology 15 (12), 1319-1331, 2014 | 864 | 2014 |
| Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis L Bruni, M Diaz, L Barrionuevo-Rosas, R Herrero, F Bray, FX Bosch, ... The Lancet global health 4 (7), e453-e463, 2016 | 862 | 2016 |
| Comprehensive control of human papillomavirus infections and related diseases FX Bosch, TR Broker, D Forman, AB Moscicki, ML Gillison, J Doorbar, ... Vaccine 31, H1-H31, 2013 | 811 | 2013 |
